FI940769A - Förfarande för framställning av 2-aminotiazolderivat - Google Patents
Förfarande för framställning av 2-aminotiazolderivat Download PDFInfo
- Publication number
- FI940769A FI940769A FI940769A FI940769A FI940769A FI 940769 A FI940769 A FI 940769A FI 940769 A FI940769 A FI 940769A FI 940769 A FI940769 A FI 940769A FI 940769 A FI940769 A FI 940769A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- aminoazole
- derivatives
- aminoazole derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9301941A FR2701708B1 (fr) | 1993-02-19 | 1993-02-19 | Dérivés de 2-amido-4-phénylthiazoles polysubstitués, procédé de préparation, composition pharmaceutique et utilisation de ces dérivés pour la préparation d'un médicament. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI940769A0 FI940769A0 (sv) | 1994-02-18 |
| FI940769A true FI940769A (sv) | 1994-08-20 |
Family
ID=9444247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940769A FI940769A (sv) | 1993-02-19 | 1994-02-18 | Förfarande för framställning av 2-aminotiazolderivat |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5656648A (sv) |
| EP (1) | EP0611766A1 (sv) |
| JP (1) | JPH06298761A (sv) |
| KR (1) | KR940019706A (sv) |
| CN (1) | CN1107158A (sv) |
| AU (1) | AU680213B2 (sv) |
| CA (1) | CA2115805A1 (sv) |
| FI (1) | FI940769A (sv) |
| FR (1) | FR2701708B1 (sv) |
| HU (1) | HUT70158A (sv) |
| IL (1) | IL108636A (sv) |
| MX (1) | MX9401209A (sv) |
| NO (1) | NO940558D0 (sv) |
| NZ (1) | NZ250907A (sv) |
| RU (1) | RU2125569C1 (sv) |
| ZA (1) | ZA941128B (sv) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE68593B1 (en) * | 1989-12-06 | 1996-06-26 | Sanofi Sa | Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them |
| FR2763337B1 (fr) * | 1997-05-13 | 1999-08-20 | Sanofi Sa | Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant |
| FR2768737B1 (fr) * | 1997-09-19 | 2000-05-19 | Sanofi Sa | Derives de carboxamidothiazoles, leur preparation, les compositions pharmaceutiques en contenant |
| CO4970713A1 (es) * | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen |
| TWI271406B (en) | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| US6768024B1 (en) | 2000-08-04 | 2004-07-27 | Lion Bioscience Ag | Triamine derivative melanocortin receptor ligands and methods of using same |
| FR2815963B1 (fr) * | 2000-10-26 | 2003-02-28 | Sanofi Synthelabo | Nouveaux derives du triazole et les compositions pharmaceutiques les contenant |
| KR20030042035A (ko) * | 2000-10-26 | 2003-05-27 | 사노피-신델라보 | 트리아졸 유도체 및 이들을 포함하는 제약 조성물 |
| GB0102668D0 (en) * | 2001-02-02 | 2001-03-21 | Glaxo Group Ltd | Compounds |
| TWI312347B (en) | 2001-02-08 | 2009-07-21 | Eisai R&D Man Co Ltd | Bicyclic nitrogen-containing condensed ring compounds |
| CZ301491B6 (cs) | 2001-04-27 | 2010-03-24 | Eisai R&D Management Co., Ltd. | Pyrazolo[1,5-a]pyridiny a léciva s jejich obsahem |
| US7176216B2 (en) | 2002-10-22 | 2007-02-13 | Eisai Co., Ltd. | 7-phenylpyrazolopyridine compounds |
| WO2004037822A1 (ja) | 2002-10-22 | 2004-05-06 | Eisai Co., Ltd. | ７−フェニルピラゾロピリジン化合物 |
| FR2872813B1 (fr) | 2004-07-09 | 2007-01-19 | Sanofi Synthelabo | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
| CN101096363B (zh) * | 2006-06-27 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 2,4,5-三取代噻唑类化合物、其制备方法、药物组合物及其制药用途 |
| NZ588376A (en) | 2008-04-15 | 2011-06-30 | Eisai R&D Man Co Ltd | 3-phenylpyrazolo[5,1-b]thiazole compound having antagonism against corticotropin-releasing factor (CRF) receptor |
| EP2299819A4 (en) * | 2008-05-19 | 2011-07-20 | Univ Tennessee Res Foundation | NON-CLASSIC CANNABINOID COMPOUNDS BASED ON PYRIDINE AND METHODS OF USE THEREOF |
| JP2011520975A (ja) * | 2008-05-19 | 2011-07-21 | ユニヴァーシティ オブ テネシー リサーチ ファウンデーション，ザ | ピリミジンの非古典的カンナビノイド化合物及び関連する使用方法 |
| AR078521A1 (es) | 2009-10-08 | 2011-11-16 | Eisai R&D Man Co Ltd | Compuesto pirazolotiazol |
| ES2557465T3 (es) | 2010-03-17 | 2016-01-26 | Taivex Therapeutics Inc. | Moduladores de la actividad de HEC 1 y procedimientos para ello |
| US11071736B2 (en) | 2011-11-21 | 2021-07-27 | Taivex Therapeutics Corporation | Modulators of HEC1 activity and methods therefor |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1526074A (fr) * | 1967-03-22 | 1968-05-24 | Rech S Ind S O R I Soc D | Méthoxy-phényl-amino-2-thiazoles, leurs amides et leurs procédés de préparation |
| FR2566405B1 (fr) * | 1984-06-25 | 1986-09-26 | Roussel Uclaf | Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus |
| DE3705934A1 (de) * | 1987-02-25 | 1988-09-08 | Nattermann A & Cie | Indolyl-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| US4971978A (en) * | 1987-09-21 | 1990-11-20 | Nadzan Alex M | Derivatives of D-glutamic acid and D-aspartic acid |
| IE68593B1 (en) * | 1989-12-06 | 1996-06-26 | Sanofi Sa | Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them |
| FR2677356B1 (fr) * | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
-
1993
- 1993-02-19 FR FR9301941A patent/FR2701708B1/fr not_active Expired - Fee Related
-
1994
- 1994-02-14 IL IL10863694A patent/IL108636A/en not_active IP Right Cessation
- 1994-02-15 AU AU55162/94A patent/AU680213B2/en not_active Ceased
- 1994-02-16 MX MX9401209A patent/MX9401209A/es unknown
- 1994-02-16 CA CA002115805A patent/CA2115805A1/en not_active Abandoned
- 1994-02-17 EP EP94400350A patent/EP0611766A1/fr not_active Withdrawn
- 1994-02-17 NZ NZ250907A patent/NZ250907A/en unknown
- 1994-02-18 FI FI940769A patent/FI940769A/sv unknown
- 1994-02-18 ZA ZA941128A patent/ZA941128B/xx unknown
- 1994-02-18 HU HU9400474A patent/HUT70158A/hu unknown
- 1994-02-18 NO NO940558A patent/NO940558D0/no unknown
- 1994-02-18 JP JP6021157A patent/JPH06298761A/ja not_active Withdrawn
- 1994-02-18 RU RU94004997A patent/RU2125569C1/ru active
- 1994-02-19 KR KR1019940003029A patent/KR940019706A/ko not_active Application Discontinuation
- 1994-02-19 CN CN94101403A patent/CN1107158A/zh active Pending
-
1995
- 1995-06-07 US US08/474,548 patent/US5656648A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU680213B2 (en) | 1997-07-24 |
| AU5516294A (en) | 1994-08-25 |
| FR2701708A1 (fr) | 1994-08-26 |
| HU9400474D0 (en) | 1994-05-30 |
| RU2125569C1 (ru) | 1999-01-27 |
| MX9401209A (es) | 1994-08-31 |
| KR940019706A (ko) | 1994-09-14 |
| CN1107158A (zh) | 1995-08-23 |
| EP0611766A1 (fr) | 1994-08-24 |
| NO940558D0 (no) | 1994-02-18 |
| FI940769A0 (sv) | 1994-02-18 |
| FR2701708B1 (fr) | 1995-05-19 |
| NZ250907A (en) | 1996-01-26 |
| JPH06298761A (ja) | 1994-10-25 |
| NO940558L (sv) | 1994-08-22 |
| ZA941128B (en) | 1995-08-18 |
| CA2115805A1 (en) | 1994-08-20 |
| IL108636A0 (en) | 1994-05-30 |
| HUT70158A (en) | 1995-09-28 |
| IL108636A (en) | 1999-04-11 |
| US5656648A (en) | 1997-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI945441A (sv) | Nytt förfarande för framställning av 7beta-substituerad-4-aza-5alfa-androstan-3-oner | |
| FI940769A (sv) | Förfarande för framställning av 2-aminotiazolderivat | |
| NO305025B1 (no) | FremgangsmÕte for fremstilling av piperidinderivater | |
| NO982237L (no) | FremgangsmÕte for fremstilling av fenylimidazolidinderivater | |
| FI95036B (sv) | Förfarande för framställning av tieno-triazolo-diazepinderivat | |
| NO941659L (no) | Fremgangsmåte for fremstilling av aluminoksaner | |
| ITMI931680A1 (it) | Procedimento per la preparazione di alcansolfonammidi | |
| EE03027B1 (et) | Meetod 8-klorokinolooni derivaatide valmistamiseks | |
| FI941397A0 (sv) | Förfarande för framställning av metylformiat | |
| NO179244C (no) | Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal | |
| NO955082L (no) | Fremgangsmåte for fremstilling av glutardialdehyd | |
| FI953361A (sv) | Förfarande för framställning av substituerade indolonderivat | |
| FI961178A0 (sv) | Förfarande för framställning av cykliska cis-1-amino-2-alkanoler | |
| FI971964A (sv) | Förfarande för framställning av 1-halo-3-trialkylsilanylbensenderivat | |
| FI943660A0 (sv) | Framställningsförfarande för 3-karbonylandrostadien-17-karboxamider | |
| NO179866C (no) | Fremgangsmåte for fremstilling av indoler | |
| NO964519D0 (no) | Fremgangsmåte for fremstilling av chitosanalkylderivater | |
| NO174196C (no) | Fremgangsmåte for fremstilling av omega-decenol | |
| FI960790A0 (sv) | Förfarande för framställning av fluorenbisfenol | |
| IS4086A (is) | Aðferð við framleiðslu efnasambanda | |
| FI932887A (sv) | Foerbaettrat foerfarande foer framstaellning av 4-nitro-3-trifluorometylanilin | |
| NO963084D0 (no) | Fremgangsmåte for fremstilling av pyrrolidinyl-acetamidderivater | |
| NO943237D0 (no) | Fremgangsmåte for fremstilling av benzotiazepinderivater | |
| FI955027A (sv) | Förfarande för framställning av en mellanprodukt | |
| FI902356A0 (sv) | Förfarande för framställning av tieno-triazolo-diazepinderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Name/ company changed in application |
Owner name: SANOFI |